Morgan Joseph Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Sees Nexavar Sales at $2 Billion By 2015
Tweet Send to a Friend
Morgan Joseph maintains a 'Buy' on Onyx Pharmaceuticals (Nasdaq: ONXX), raises price target to $45.
Morgan analyst says, "A strong ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "A strong ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
